Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
DOI:
https://doi.org/10.3329/mediscope.v12i2.84134Keywords:
Neonatal Jaundice, Irradiation spectrum, Phototherapy, BilirubinAbstract
Background: Hyperbilirubinemia is a common problem in full-term newborns. Since the 1950s, phototherapy has been the choice of treatment for lowering bilirubin concentration in neonates.
Objective: To compare the effectiveness of single and double phototherapy and increasing spectral irradiance for decreasing serum bilirubin levels in neonates with indirect hyperbilirubinemia.
Methods: An open-label, randomized controlled trial was conducted at Ad-din Sakina Women's Medical College, Jashore, from June to December 2022. Subjects were divided into two groups: those who received single phototherapy (n=35) and those who received double phototherapy (n=35). We included term newborns with neonatal jaundice in the first week of life. Serum bilirubin and average spectral irradiation levels were measured at baseline and after 12 hours and 24 hours of phototherapy treatment.
Results: The mean total bilirubin levels of the single and double phototherapy groups at the beginning of therapy were 17.6±1.41 mg/dL and 17.5±1.32 mg/dL, respectively, with no significant difference between values. During the study period, the sum of average spectral irradiance by double phototherapy was significantly higher than that of single phototherapy (P < 0.05). A significantly greater decrease in bilirubin levels was observed in the double phototherapy group at 12 hours and 24 hours of phototherapy compared to the single phototherapy group (P <0.001).
Conclusion: Double phototherapy is more effective than single phototherapy in reducing bilirubin levels in jaundiced newborns.
Mediscope 2025;12(2): 66-71
Downloads
0
0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kazi Zamir Hossain, Ehsanul Kabir, Kishor Kumar Biswas

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Mediscope agree to the following terms that:
- Authors retain copyright and grant Mediscope the right of first publication of the work.
Articles in Mediscope are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.